US Patent Issued to Research Institute at Nationwide Children's Hospital on April 1 for "Gene therapy for limb-girdle muscular dystrophy type 2C" (Ohio Inventor)

ALEXANDRIA, Va., April 2 -- United States Patent no. 12,263,230, issued on April 1, was assigned to Research Institute at Nationwide Children's Hospital (Columbus, Ohio).

"Gene therapy for limb-girdle muscular dystrophy type 2C" was invented by Louise R. Rodino-Klapac (Columbus, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to gene therapy vectors, such as AAV vectors, comprising a polynucleotide encoding Gamma-sarcoglycan (SGCG) and methods of using such gene therapy vectors to treat subjects suffering from a muscular dystrophy, e.g. limb girdle dystrophy type 2C (LGMD2C)."

The patent was filed on Jan. 30, 2019, under Application No. 16/966,407.

*For further information, inclu...